Diagnosis of Deep Septic Thrombophlebitis in Cancer Patients by Fluorine-18
Fluorodeoxyglucose Positron Emission Tomography Scanning:
A Preliminary Report
Marisa Miceli, Rola Atoui, Ronald Walker, Tahsine Mahfouz, Nadeem Mirza,
Jose Diaz, Guido Tricot, Bart Barlogie, and Elias Anaissie
Journal of Clinical Oncology 22:1949-1956, May 2004
Purpose
To determine the role of the fluorine-18 fluorodeoxyglucose positron emission
tomography (FDG-PET) scan in the diagnosis and management of deep septic
thrombophlebitis (STP).
Patients and Methods
We conducted a prospective observational evaluation of FDG-PET in patients
with cancer and suspected STP. Retrospective evaluation of patients with
cancer and deep venous thrombosis (DVT) who underwent FDG-PET and extremity
duplex scan (DS) was also performed.
Results
Strong venous uptake was observed in FDG-PET of nine STP episodes versus 0 of
27 DVT episodes (P < .001). FDG-PET identified central vein STP in five
patients, whereas DS and venography were negative in five and two of these
patients, respectively. FDG-PET diagnosis of STP resulted in therapeutic
changes in all patients. In four patients, follow-up FDG-PET confirmed
resolution.
Conclusion
In cancer patients, FDG-PET identifies STP even in areas not optimally
visualized by DS or venography, distinguishes STP from DVT, and leads to
significant therapeutic changes.
*A PDF file viewer is required to view pdf documents. If you do not have one
already, you may download the necessary software from one of the following
sites:
Acrobat Reader
Ghostscript (and Ghostview and GSview)
Xpdf (for Unix)
If you have questions about this page or experience technical difficulties, please alert the web master.
This site is created and maintained by the UAMS Radiology Department.